The candidates will make their final offer on March 13th. All Medley employees must be retained for one year, including the CEO. Sanofi has already warned that the deal will not go through for less ...

CVC Brasil's market value on the B3 stock exchange is R$ 1.35 billion. The former president of CVC Brasil Operadora e Agência de Viagens, Luiz Fernando Fogaça, has become a defendant in an ...

CVC Brasil's market value on the B3 stock exchange is R$ 1.35 billion. The former president of CVC Brasil Operadora e Agência de Viagens, Luiz Fernando Fogaça, has become the defendant in an ...

The main private equity funds (FIPs) managed by MAM Asset, a management company of the Master group, are structures used by businessman Nelson Tanure, who is being investigated by the Federal Police ...

After 13 years under the management of the French company Servier, the Brazilian pharmaceutical company Pharlab has returned to national control. A group of investors, led by Nelson Libbos, former CEO ...

Sanofi's market capitalization is €94.5 billion. Amid the sale process of Medley, its Brazilian generic drug unit, the French pharmaceutical company Sanofi projects a capital gain of approximately ...

The new group is valued at R$ 2.98 billion. Now, with the green light to move forward, the group, renamed Petz Cobasi, is finally beginning to implement the steps of the two operations. And the ...

Tesla 's fourth-quarter and 2025 earnings reports, led by Elon Musk, reflected the impacts on the automaker's sales following factors such as the end of subsidies for electric cars in the US and the ...

The digital bank closed its order book and will begin trading on Nasdaq on January 29th, with shares priced at $19. Investor demand was close to 13 times higher. Carlos Sambrana 28/01/26 19:50 New ...

Demand for the company's shares has surprised even those who had high expectations. The additional allotment is expected to be offered, and the closing price will be announced in the next few hours.

A report by Apollo Global Management projects that, by 2030, half of the top 10 borrowers in the U.S. bond market will be hyperscale companies operating large technology structures. The rampant ...

The pharmaceutical industry has ten to fifteen different types of drugs in the development pipeline, says Wanderley. At Assaí, the strategy was to keep up with the demand for products more closely ...